Wegovy Vs Ozempic. What's The Difference?

What’s the difference between Wegovy and Ozempic?

Wegovy and Ozempic both contain semaglutide, but they’re approved for different uses in the EU. Wegovy is used for weight loss and is available in a higher dose (2.4 mg), whereas Ozempic is approved for the treatment of type 2 diabetes and is administered in lower doses. Wegovy typically leads to more significant weight loss but may be more challenging to access and more expensive.

 

 

Wegovy vs Ozempic in the EU: Differences, Dosage & Availability

More and more people in Europe are struggling with being overweight or obese. This can lead to serious health problems like heart disease and type 2 diabetes. Treating these issues is costly, so doctors are seeking new ways to help people lose weight.

 

One group of medicines called GLP-1 receptor agonists (GLP-1 RAs) is showing promise. These medicines were initially developed for people with diabetes, but they also aid in weight loss. Two well-known versions are Ozempic and Wegovy.

 

Ozempic has been approved in Europe since 2018 for use in people with type 2 diabetes. It lowers blood sugar and helps people lose some weight, too. Some people use it for weight loss even though that’s not its primary use.

 

Wegovy is newer. It was approved in 2022 in Europe just to help people lose weight. In extensive medical studies, known as the STEP trials, people using Wegovy lost 10–16% of their body weight within a year.

 

As these medicines become more popular, it’s essential to understand the differences between them, such as how they're approved in Europe, how they’re taken, how well they work, and what side effects they may have.

 

In this guide, we’ll look at:

 

• How do these medicines work in your body
• What they’re approved for in different European countries
• How often do you take them, and how do the doses increase
• Results from medical studies and real-life use
• Safety and side effects to watch for
• How easy they are to get, how much they cost, and whether insurance helps
• Tips for patients and doctors who are thinking about using them

 

By the end, you’ll have a clearer picture of which treatment might be right for you or someone you care about. Whether you’re just learning about weight loss medicines or talking to a doctor, this guide will help you make smart choices based on the facts.

What Is Semaglutide and How Does It Work?

Ozempic and Wegovy are both medicines that contain the same ingredient: semaglutide. This is a man-made version of a hormone your body makes in the gut called GLP-1 (glucagon-like peptide-1).

 

Semaglutide was first made to help people with type 2 diabetes, but doctors later saw that it also helps people lose weight. Even though Ozempic and Wegovy have the same main ingredient, they’re used in slightly different ways and at various doses.

How Does Semaglutide Work?

Semaglutide is part of a group of medicines called GLP-1 receptor agonists. These drugs copy the action of your body’s natural GLP-1 hormone. They work in a few helpful ways:

 

• Helps your pancreas produce more insulin when your blood sugar levels are high.
• Lowers glucagon, a hormone that raises blood sugar.
• Makes you feel full, so you’re less hungry and eat less.
• It slows down digestion, so food stays in your stomach longer, and you feel full for longer.

 

All these effects help people lose weight and manage their blood sugar levels more effectively.

Semaglutide and Weight Loss: What the Science Shows

In one critical study, people who took semaglutide once a week ate around 40% less food after 20 weeks. They also lost approximately 10% of their body weight, which is a significant amount. This occurred without any long-term digestive problems.

 

Other studies have also shown that semaglutide makes people feel full after eating by slowing the rate at which food leaves the stomach. This is part of why people on semaglutide tend to eat less and lose weight.

Why Is Semaglutide Better Than Other Weight Loss Drugs?

Studies show that semaglutide works better than many older weight-loss medicines because it does three things at once:

 

• Reduces hunger
• Slows digestion
• Improves how your body handles sugar

 

Semaglutide may also help protect your heart and kidneys, making it even more beneficial.

Same Ingredient, Different Goals: Ozempic vs. Wegovy

Even though both Ozempic and Wegovy use semaglutide, they’re made for different reasons:

 

• Ozempic has been used in Europe since 2018 to help people with type 2 diabetes. It also helps some people lose weight, but that’s not its primary purpose.
• Wegovy was approved in 2022 just for weight loss in people who are obese or overweight with other health problems.

 

The big difference is the dose. Wegovy uses higher doses of semaglutide to focus on weight loss. Ozempic uses lower doses primarily to help control blood sugar levels.

Regulatory Status & Indications in the EU

Both Ozempic and Wegovy use the same ingredient—semaglutide—but they are approved for different uses in Europe. Although they work similarly in the body, they are used for other health issues and follow distinct guidelines for doctors and patients.

Who Can Use Each One?

Ozempic

• Only for adults with type 2 diabetes.
• It can aid in weight loss, but that’s not its primary purpose. Using it just for weight loss is called off-label, and it’s not officially approved for that in Europe.

Wegovy

 

• For adults with:
  • Obesity (BMI of 30 or more), or
  • Overweight (BMI of 27 or more) plus at least one weight-related problem (like high blood pressure or high cholesterol).
• It is also approved for teenagers 12 and older who are obese and weigh more than 60 kg.

 

Doctors must stop Wegovy if it doesn’t help the person lose at least 5% of their body weight within 12 weeks on the highest dose.

Safety Labels and Warnings

The EMA (European Medicines Agency) carefully reviews both medicines and updates the safety guidelines as needed. Recently, both Ozempic and Wegovy were updated to warn about a rare but serious eye problem called NAION (a type of vision loss).

Using Ozempic for Weight Loss: What’s the Issue?

Even though Ozempic is only approved for diabetes, many people and doctors still use it for weight loss. This is called off-label use. Because of this, some European countries have set rules about who can get these medicines, such as:

 

• Only people with a very high BMI
• Or only through a specialist doctor or clinic

 

Quick Comparison Table

 

Feature	Ozempic (EU)	Wegovy (EU)
Year Approved	2018 (for diabetes)	2022 (for weight loss)
Who It’s For	Adults with type 2 diabetes	Adults and teens with obesity or overweight and another health issue
Use in Teenagers	Not allowed	Approved for teens 12+ who weigh over 60 kg
Weight Loss Purpose	Not officially approved (off-label)	Primary approved use: must lose at least 5% body weight in 12 weeks
Safety Warning	Possible rare vision problem (NAION)	The same vision warning applies

 

Wegovy and Ozempic Dosage Comparison: Weekly Use and Titration

Even though Ozempic and Wegovy use the same ingredient (semaglutide), the amount you take and how you increase the dose over time is different. This is because Ozempic is approved for diabetes treatment, and Wegovy is approved for weight loss.

 

Let’s break it down in a simple way.

Ozempic for Type 2 Diabetes

How the dose increases:

 

• Week 1: Start with 0.25 mg once a week (this helps your body adjust to the medication; it's not the final dose).
• After 4 weeks: Go up to 0.5 mg weekly.
• After another 4 weeks (or more), you may increase to 1 mg if needed.
• Optional: If blood sugar levels are still too high, your doctor may increase the dose to 2 mg, but no more than that.

 

How it’s taken:

Ozempic comes in a multi-use injection pen. You use the same pen each week until it runs out, but change the needle every time.

Missed a dose?

If it’s been less than 5 days, you can still take it. If it’s been more than 5 days, skip that week and just take the next dose as usual.

Wegovy – for Weight Loss

How the dose increases:

• Weeks 1–4: Start with 0.25 mg weekly.
• Weeks 5–8: Increase to 0.5 mg weekly.
• Weeks 9–12: Go up to 1 mg weekly.
• Weeks 13–16: Increase to 1.7 mg weekly.
• Week 17 and onward: Stay at 2.4 mg weekly. This is the full dose for weight loss.

How it’s taken:

Wegovy comes in single-use pens. You discard the pen after each use and replace it with a new one every week.

Quick Comparison Table

 

Feature	Ozempic (for Diabetes)	Wegovy (for Weight Loss)
Start Dose	0.25 mg → 0.5 mg after 4 weeks	0.25 mg → 0.5 mg after 4 weeks
Middle Steps	1 mg → maybe 2 mg	1 mg → 1.7 mg → 2.4 mg
Top Dose	2 mg (optional)	2.4 mg (standard)
Pen Type	Reusable pen (multi-use)	One-time pen (use once, then bin it)
Main Goal	Lower blood sugar	Help you lose weight
Missed Dose Rule	Take it within 5 days or skip	A similar rule applies

Why Do the Doses Go Up Slowly?

These medicines can cause side effects such as nausea, bloating, or diarrhea, especially when first started. By increasing the dose slowly, your body has time to adjust, and you’re less likely to feel sick.

 

Wegovy has more steps and a higher final dose because it needs to be strong enough to help people lose a lot of weight. In studies, people lost 10–16% of their body weight after more than a year on the full dose.

What This Means for You

• Both medicines are taken once a week with a small injection under the skin.
• Ozempic’s pen can be used many times, while Wegovy’s pen is single-use—you need a new one each week.
• Wegovy costs more since the dose is higher and you use more pens.
• If you’re on Wegovy, your doctor will monitor your progress frequently, especially during the first few months, to ensure it’s working and safe.

Efficacy: Weight Loss & Metabolic Benefits

Ozempic and Wegovy both aid in weight loss and health improvements, but they do so in distinct ways and to varying degrees. Let’s break down what studies have shown.

Wegovy Studies on Weight Loss

Wegovy was tested in extensive studies called STEP trials. These studies were conducted to determine how effectively it helps people lose weight when used in conjunction with a healthy lifestyle.

 

• In trials like STEP 1, 3, 4, and 8, people using Wegovy lost about 15% to 17% of their body weight over 68 weeks (just over a year).
• In STEP 5, some people maintained their weight for 2 years, and over a third lost 20% or more of their starting weight.
• Around half of the people in the study dropped at least one BMI level, and 12% reached a healthy BMI, compared to only 1.2% in the group not using Wegovy.
• It also helped improve other health indicators, including a smaller waist, lower blood pressure, better cholesterol levels, lower blood sugar, and an enhanced quality of life.

 

In real life, people tend to lose a bit less weight than in studies—about 12%—due to factors such as lower doses, stopping early, or difficulty administering the medicine.

Ozempic Studies for Diabetes (and Weight Loss)

Ozempic was made for people with type 2 diabetes, but it also helps with weight loss:

 

• In SUSTAIN trials, people taking Ozempic lost about 4 to 5 kilograms (around 6–7% of their body weight).
• It also helped lower HbA1c, a measure of blood sugar, by 2% to 1.8%.
• In another study, individuals with diabetes lost approximately 5.6 kg over 2 years.

 

So, while Ozempic does help with weight, it doesn't work as well for weight loss as Wegovy.

Comparing Wegovy and Ozempic

There haven’t been any direct studies in Europe that compare Ozempic and Wegovy head-to-head. But we can still see some apparent differences:

 

• Wegovy uses a higher dose, and that’s why it leads to more weight loss.
• People on Wegovy reach the full dose (2.4 mg) in about 16 weeks.
• Higher doses help people feel fuller, eat less, and improve their metabolism more.

Health Benefits Beyond Weight Loss

Both Ozempic and Wegovy help with more than just weight:

 

• Ozempic lowers blood sugar a lot (by 1.2–1.8%) and can slightly lower blood pressure and improve cholesterol.
• Wegovy does all that, too—even in people without diabetes. It helps lower waist size, blood fat, and inflammation and boosts quality of life.

Real-Life Results

A recent study of nearly 8,000 adults with severe obesity showed:

 

• People who kept using the medicine lost about 12% of their weight.
• People who quit early (within the first 3 months) lost only about 3.6%.
• Others who stopped before 12 months lost around 6.8%.

 

Why do people stop early? Reasons include:

 

• High cost
• Side effects
• Trouble getting the medicine
• Insurance does not cover it

 

These issues are common across Europe.

 

Quick Summary Table

 

Feature	Wegovy	Ozempic
Main Use	Weight loss	Type 2 diabetes
Weekly Dose	2.4 mg	1–2 mg
Average Weight Loss	15–17% (trials) / ~12% (real life)	6–7%
Blood Sugar Improvement	Yes (even without diabetes)	Strong effect for diabetics
Approved In	2022	2018
Teen Approval	Yes (12+ years)	No
Injection Pen Type	Single-use	Reusable
Common Side Effects	Nausea, diarrhoea, tiredness	Similar, but often milder
Cost (EU Average)	€270–350/month	€60–110/month
Public Coverage	Limited	Broad (for diabetes)

What Does This Mean for You?

• Want to lose a lot of weight? Wegovy is better for that.
• Have diabetes? Ozempic is an excellent choice for lowering blood sugar and also helps with weight loss.
• Stopping the medicine can lead to weight gain, so staying on it gives the best long-term results.
• Real-life issues, such as cost, supply, and side effects, can impact how well these medicines work for different individuals.

Wegovy vs Ozempic Side Effects and Safety Warnings

Semaglutide (the ingredient in Ozempic and Wegovy) works well, but like all medicines, it can cause side effects. Some are common and mild, while others are rare and more serious. It’s essential to know what to expect and when to seek assistance.

Common Side Effects: Tummy Troubles

Most people feel some stomach-related side effects when starting Wegovy or Ozempic. These are very common and usually resolve after a few weeks.

 

Common problems include:

 

• Feeling sick (nausea)
• Being sick (vomiting)
• Diarrhoea
• Constipation
• Stomach pain or bloating

Up to 75% of people feel nausea at first, especially during the early dose increases.

 

Tips to feel better:

 

• Start with small, light meals
• Avoid greasy or fatty foods
• Eat slowly and chew well
• Drink plenty of water

 

These tricks can make a big difference.

Other Mild Side Effects

Some people also get:

 

• Redness or itching where the injection was given (more common with Wegovy pens)
• Headaches
• Tiredness
• Dizziness
• Hair thinning or loss (reported more with Wegovy)

Rare but Serious Side Effects

Some side effects are infrequent but more serious. Doctors and patients need to be vigilant.

Eye problems – NAION

This is a rare condition that can cause sudden loss of vision. It’s called Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION). It may affect about 1 in 10,000 people.

 

If you suddenly have blurry vision or vision loss, stop the medicine and see a doctor right away.

Pancreatitis (swelling of the pancreas)

• Some people may experience pain in the upper abdomen or back—this could indicate pancreatitis.
• If this happens, the medicine should be stopped immediately.

Cancer worries?

• Animal studies have shown a risk of thyroid tumors, but this has not been observed in humans.
• Extensive reviews of studies found no extra cancer risk in people using semaglutide.

Other Safety Notes

Eye problems in people with diabetes:

If you have a diabetic eye disease, your vision might get worse if your blood sugar improves too quickly. Doctors will be careful with this.

Hormone medicines:

In some cases, Wegovy may slow down how the body absorbs pills, like the contraceptive pill or HRT. The UK’s health agency recommends thinking about non-pill options for birth control or hormone treatment.

Gallbladder problems:

Some people may develop gallstones while using semaglutide, though this is still being studied.

Ongoing Safety Checks

In the UK and across Europe:

 

• Wegovy has a black triangle label, indicating it’s being closely monitored for side effects.
• Doctors and patients should report any problems they notice.
• European health agencies continually update the safety information. For example, the NAION eye issue was added in 2025 after new reports came in.

Quick Summary: What to Know

 

Type of Side Effect	What to Expect
Tummy problems (nausea, diarrhoea, etc.)	Very common at the start; it usually goes away
Vision problems	Very rare but serious; get medical help quickly
Pancreatitis	Watch for stomach pain; stop the medicine if it happens
Cancer worries	No confirmed risk in humans
Other issues	It may affect hormone pills and the gallbladder in some cases

 

Most side effects are mild and manageable.

Serious ones are rare but need fast attention.

Always talk to your doctor if you feel something isn’t right.

 

Wegovy and Ozempic Price Comparison and EU Availability in 2025

Access to Wegovy and Ozempic across Europe varies significantly by country, shaped by national regulations, reimbursement policies, and supply issues. Here’s a thorough dive into availability, pricing, and financial implications tailored for EU readers.

How Much Do They Cost in Different Countries?

Prices vary a lot across Europe. Here are some examples of monthly prices:

 

Country	Ozempic (1 mg)	Wegovy (2.4 mg)
Germany	€59	€170–300
France	€83	€270–330 (not covered by public health)
UK	£96 (€110)	£82 (€95) – private only
Netherlands	~€103	~€296

 

In Europe, these drugs are much cheaper than in the USA—about half the price or less.

Does Insurance Pay for It?

In many EU countries, public insurance does not cover weight-loss drugs unless there are serious health risks.

 

• Germany: Wegovy is now covered for people with heart risks but not for general weight loss. Ozempic is covered for diabetes.
• France: Wegovy is not reimbursed by public insurance.
• UK: The NHS covers Ozempic for the treatment of diabetes. Wegovy is covered for weight loss, but only for up to 2 years and only for individuals who meet specific eligibility criteria.

 

Poland: Ozempic is reimbursed for diabetes treatment (approximately €28 per month) and is often used off-label for weight loss through online doctors.

Private Access & Out-of-Pocket Costs

If public insurance doesn’t cover these medicines, people have to pay for them themselves:

 

• In Germany, people often pay around €300 per month for Wegovy from private clinics.
• In the UK, you can get Wegovy through private clinics for around £95/month.
• Some clinics include coaching or health check-ups in the price.

Shortages & Supply Problems

Because of very high demand, both Wegovy and Ozempic have been in short supply:

 

• Ozempic was hard to find in some countries, such as Germany, through late 2024.
• To help, health agencies advised doctors to reserve these medicines for patients who genuinely need them.

Are They Worth the Money?

Even though these medicines are expensive, they may save money in the long run by helping people avoid serious diseases linked to obesity (like diabetes and heart disease).

But:

• If you stop the medicine, many people regain weight (often around two-thirds of what they lost).
• Not everyone can afford it, and this creates unequal access between those who can and those who cannot pay.

 

Simple Summary for EU Readers

 

Topic	Ozempic	Wegovy
Use	Diabetes (some use it for weight loss)	Approved for weight loss
Availability	Easy to get for diabetes	Limited, often private only
Public Coverage	Yes, in most EU countries	Rare; limited to exceptional cases
Cost (Private)	€59–110/month	€170–395/month
Shortages	Ongoing in some areas	Also affected
Worth it?	Yes, especially for diabetes	Helpful for weight loss, but it can be costly and may not always be covered.

 

Switching Between Ozempic and Wegovy: EU Guidelines and Patient Advice

Doctors across Europe are adapting their use of semaglutide. It started as a medicine for diabetes, but now it's also used a lot for weight loss. Let's examine how and why patients switch between Ozempic and Wegovy, as well as the rules and real-life challenges associated with this decision.

Why Do People Switch?

Doctors may switch patients between Ozempic and Wegovy based on their health needs:

 

From Ozempic to Wegovy:

If someone is already on Ozempic for diabetes and wants more substantial weight loss, they may consider switching to Wegovy. Wegovy uses a higher dose (2.4 mg) that helps with weight loss more effectively.

From Wegovy to Ozempic:

If a person is more focused on controlling their blood sugar or needs a cheaper option, Ozempic might be a better fit.

Based on insurance or country rules:

Some European countries only cover Ozempic for diabetes, not Wegovy, so individuals may need to switch depending on what their health system allows.

Who Can Get Wegovy?

Across Europe, there are rules about who is allowed to take Wegovy:

 

• Adults:
• Must have a BMI of 30 or more (obesity) or a BMI of 27 or more with at least one health problem linked to weight (like high blood pressure or prediabetes).
• Teenagers (12+):
• Must have a very high BMI for their age and weigh over 60 kg.

 

If someone doesn’t lose at least 5% of their body weight after 12 weeks at the full dose, doctors are told to stop the treatment.

 

In Germany, patients must undergo a special weight-loss program before they can obtain a Wegovy prescription from a specialist.

How Do Doctors Switch Someone from Ozempic to Wegovy?

Here’s what usually happens:

• Assessment: The doctor checks the patient's weight, BMI, and health status, and discusses their goals.
• Starting Wegovy: If the person is already taking 2 mg of Ozempic, they may begin Wegovy at a lower dose (0.5 mg) for a couple of weeks to adjust to it.
• Titration (Dose Increases): The doctor increases the dose every 4 weeks until the full 2.4 mg dose is reached.
• Monitoring: Doctors track the patient's weight loss and look for any side effects that may occur. If there’s not enough weight loss, treatment may be stopped.

Easy Summary: Switching in Europe

 

What’s Happening	What It Means
People switch between Ozempic and Wegovy	Depending on whether the focus is on blood sugar or weight loss
There are strict rules	Only certain people can take Wegovy (based on BMI and health problems)
Dose increases are done slowly	To reduce side effects and check it’s working
Not everyone stays on the medicine	Side effects, high costs, and lack of support can be barriers
Support and education are key	Success depends on clear advice, good follow-up, and fair access.

 

Frequently Asked Questions About Wegovy and Ozempic in Europe)

 

Can you use Ozempic for weight loss in Europe?

Ozempic is officially approved only for type 2 diabetes in Europe. While some doctors prescribe it off-label for weight loss, this is not its primary use, and it may not be covered by insurance.

 

Is Wegovy approved for teenagers in the EU?

Yes, Wegovy is approved for teens 12 years and older who have obesity and weigh more than 60 kg.

 

Which works better for weight loss: Wegovy or Ozempic?

Wegovy leads to more weight loss than Ozempic because it uses a higher dose of semaglutide (2.4 mg weekly vs. up to 2 mg for Ozempic). Clinical trials show average weight loss with Wegovy is 15–17%, compared to 6–7% with Ozempic.

 

Why do Wegovy and Ozempic have different prices and access rules?

Wegovy is a newer medication designed specifically for weight loss, whereas Ozempic is used to treat diabetes. As a result, Wegovy is often more expensive, and insurance coverage varies by country.

 

What’s the biggest downside of Wegovy or Ozempic?

The main downsides are cost, supply shortages, and gastrointestinal side effects. Most side effects are mild; however, stopping the medication often results in weight regain.

 

Conclusion

Wegovy and Ozempic are two medicines that help people with weight loss and diabetes. Although they both use the same ingredient (semaglutide), they are used in different ways.

 

Wegovy is made to help people who are overweight or have obesity lose weight. It is administered once a week in a higher dose, and studies show that people can lose a significant amount of weight, sometimes up to 15% of their body weight. It’s a powerful option for individuals seeking to improve their health through weight loss.

 

Ozempic, on the other hand, is primarily used for individuals with type 2 diabetes. It helps lower blood sugar and also aids in some weight loss, although not as significantly as Wegovy. One significant benefit is that Ozempic is more readily available in many European countries and is often covered by health insurance when used to treat diabetes.

 

However, there are factors to consider before choosing either medicine. Wegovy is more expensive, and many people have to pay for it themselves. Both drugs can cause side effects like nausea and stomach problems, especially in the first few weeks. Additionally, people need to take them once a week and follow the dose schedule closely. If someone stops taking the medicine, they may regain the weight they lost.

 

Ultimately, the choice between Wegovy and Ozempic depends on your specific health goals. If you want to lose a lot of weight and have health problems because of it, Wegovy might be a better choice. If you have diabetes and want to improve your blood sugar while losing some weight, Ozempic could work well. Consult your doctor to find the medication that best suits your needs, and always follow a healthy lifestyle in conjunction with your treatment.